University Hospital Center Dr Dragiša Mišović or Clinical Hospital Center Dr Dragiša Mišović Dedinje, is a health facility of secondary level in Belgrade, that performs specialist health care in its hospitals and clinics. It is based on modern principles of health care.

There are 546 (2017) beds in Clinical Hospital Center "Dr Dragisa Misovic-Dedinje".

During the past decade, Clinical Hospital Center "Dr Dragisa Misovic-Dedinje" conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 9 clinical trials were completed, i.e. on average, 32.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Hospital Center "Dr Dragisa Misovic-Dedinje"" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "ACADIA Pharmaceuticals Inc." with 3 trials sponsored, "Celgene" with 3 trials sponsored, "Sunovion" with 3 trials sponsored and "Arena Pharmaceuticals" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Hospital Center "Dr Dragisa Misovic-Dedinje"" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Bucharest Emergency Hospital" with 1 trials as a collaborator, "Coordinating Centre for Clinical Trials, Charité" with 1 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator and "Echo Core Lab Berlin" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Hospital Center "Dr Dragisa Misovic-Dedinje"" are "Ulcerative Colitis" (5 trials), "Crohn Disease" (4 trials), "Bipolar I Disorder" (3 trials), "Depressive Disorder, Major" (3 trials) and "Adjunctive Treatment of Major Depressive Disorder" (2 trials). Many other conditions were trialed in "Clinical Hospital Center "Dr Dragisa Misovic-Dedinje"" in a lesser frequency.

Most popular intervention types in "Clinical Hospital Center "Dr Dragisa Misovic-Dedinje"" are "Drug" (27 trials), "Other" (4 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Etrasimod" (4 trials), "Ozanimod" (3 trials), "Aticaprant" (2 trials) and "Lurasidone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Hospital Center "Dr Dragisa Misovic-Dedinje"" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Hospital Center "Dr Dragisa Misovic-Dedinje"". undefined are not yet recruiting, 13 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Clinical Hospital Center "Dr Dragisa Misovic-Dedinje", undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Hospital Center "Dr Dragisa Misovic-Dedinje", 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".